Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review.

Bennett WL, Odelola OA, Wilson LM, Bolen S, Selvaraj S, Robinson KA, Bass EB, Puhan MA.

Ann Intern Med. 2012 Jan 3;156(1 Pt 1):27-36. doi: 10.7326/0003-4819-156-1-201201030-00005. Review.

PMID:
22213492
2.

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations.

Bennett WL, Maruthur NM, Singh S, Segal JB, Wilson LM, Chatterjee R, Marinopoulos SS, Puhan MA, Ranasinghe P, Block L, Nicholson WK, Hutfless S, Bass EB, Bolen S.

Ann Intern Med. 2011 May 3;154(9):602-13. doi: 10.7326/0003-4819-154-9-201105030-00336. Epub 2011 Mar 14. Review. Erratum in: Ann Intern Med. 2011 Jul 5;155(1):67-8.

3.

Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.

Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, Wiley C, Selvin E, Wilson R, Bass EB, Brancati FL.

Ann Intern Med. 2007 Sep 18;147(6):386-99. Epub 2007 Jul 16. Review. Erratum in: Ann Intern Med. 2007 Dec 18;147(12):887.

PMID:
17638715
4.

AHRQ's comparative effectiveness research on oral medications for type 2 diabetes: a summary of the key findings.

Bennett WL, Balfe LM, Faysal JM.

J Manag Care Pharm. 2012 Jan-Feb;18(1 Suppl A):1-22. Review.

5.

Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.

Waugh N, Cummins E, Royle P, Clar C, Marien M, Richter B, Philip S.

Health Technol Assess. 2010 Jul;14(36):1-248. doi: 10.3310/hta14360. Review.

6.

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians.

Qaseem A, Barry MJ, Humphrey LL, Forciea MA; Clinical Guidelines Committee of the American College of Physicians.

Ann Intern Med. 2017 Feb 21;166(4):279-290. doi: 10.7326/M16-1860. Epub 2017 Jan 3.

PMID:
28055075
7.

Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin.

Goergen SK, Rumbold G, Compton G, Harris C.

Radiology. 2010 Jan;254(1):261-9. doi: 10.1148/radiol.09090690. Review.

PMID:
20032157
8.

Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians.

Qaseem A, Humphrey LL, Sweet DE, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians.

Ann Intern Med. 2012 Feb 7;156(3):218-31. doi: 10.7326/0003-4819-156-3-201202070-00011. Erratum in: Ann Intern Med. 2012 May 15;156(10):756. Ann Intern Med. 2012 Jul 17;157(2):152.

PMID:
22312141
9.

OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.

Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P.

Osteoarthritis Cartilage. 2007 Sep;15(9):981-1000. Epub 2007 Aug 27. Review.

10.

Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.

Berkowitz SA, Krumme AA, Avorn J, Brennan T, Matlin OS, Spettell CM, Pezalla EJ, Brill G, Shrank WH, Choudhry NK.

JAMA Intern Med. 2014 Dec;174(12):1955-62. doi: 10.1001/jamainternmed.2014.5294.

PMID:
25347323
11.

Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.

Holmer HK, Ogden LA, Burda BU, Norris SL.

PLoS One. 2013;8(4):e58625. doi: 10.1371/journal.pone.0058625. Epub 2013 Apr 5.

12.

Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation.

Czoski-Murray C, Warren E, Chilcott J, Beverley C, Psyllaki MA, Cowan J.

Health Technol Assess. 2004 Apr;8(13):iii, ix-x, 1-91. Review.

13.

Evaluation of guidelines on diabetes medication.

Giaccari A, Giorda CB, Riccardi G, De Micheli A, Bruno G, Monge L, Frontoni S.

Ann Intern Med. 2012 May 15;156(10):752-3; author reply 753. doi: 10.7326/0003-4819-156-10-201205150-00020. No abstract available.

PMID:
22586015
14.

Evaluation of guidelines on diabetes medication.

Brown K, Harbour R, Petrie J.

Ann Intern Med. 2012 May 15;156(10):752; author reply 753. doi: 10.7326/0003-4819-156-10-201205150-00019. No abstract available.

PMID:
22586014
15.

Development of heart failure in Medicaid patients with type 2 diabetes treated with pioglitazone, rosiglitazone, or metformin.

Breunig IM, Shaya FT, McPherson ML, Snitker S.

J Manag Care Spec Pharm. 2014 Sep;20(9):895-903.

16.

The Scientific Basis of Guideline Recommendations on Sugar Intake: A Systematic Review.

Erickson J, Sadeghirad B, Lytvyn L, Slavin J, Johnston BC.

Ann Intern Med. 2017 Feb 21;166(4):257-267. doi: 10.7326/M16-2020. Epub 2016 Dec 20. Review.

PMID:
27992898
18.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
19.

Clinical guidelines for postpartum women and infants in primary care-a systematic review.

Haran C, van Driel M, Mitchell BL, Brodribb WE.

BMC Pregnancy Childbirth. 2014 Jan 29;14:51. doi: 10.1186/1471-2393-14-51. Review.

20.

Thiazolidinediones in type 2 diabetes: a cardiology perspective.

Khanderia U, Pop-Busui R, Eagle KA.

Ann Pharmacother. 2008 Oct;42(10):1466-74. doi: 10.1345/aph.1K666. Epub 2008 Sep 2. Review.

PMID:
18698014

Supplemental Content

Support Center